Skip to main content
SpringerLink
Log in

Cancer de l’Œsophage

  • Chapter
Les cancers digestifs

Part of the book series: Oncologie Pratique ((ONCOLPRAT))

  • 321 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Kulling D, Feldman DR, Kay CL et al. (1998) Local staging of esophageal cancer using endoscopic magnetic resonance imaging: prospective comparison with endoscopic ultrasound. Endoscopy 30: 745–9

    CAS  PubMed  Google Scholar 

  2. Bonvalot S, Bouvard N, Lothaire P et al. (1996) Contribution of cervical ultrasound fineneedle aspiration biopsy to the staging of thoracic esophageal carcinoma. Eur J Cancer 32: 893–5

    Article  Google Scholar 

  3. Sharma VK, Chokalingam H, Hornung CA et al. (1998) Changing trends in esophageal cancer: a 15-year experience in a single center. Am J Gastroenterol 93: 702–5

    CAS  PubMed  Google Scholar 

  4. Faivre J, Forman D, Estève J et al. (1998) Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 34: 2167–75

    CAS  Google Scholar 

  5. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220: 364–73

    CAS  PubMed  Google Scholar 

  6. Shimada Y, Imamura M, Watanabe G et al. (1999) Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80: 1281–8

    Article  CAS  PubMed  Google Scholar 

  7. Lim JT, Truong PT, Berthelet E et al. (2003) Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 57: 1328–35

    Article  PubMed  Google Scholar 

  8. Glickman JN, Torres C, Wang HH et al. (1999) The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 85: 769–78

    Article  CAS  PubMed  Google Scholar 

  9. Birkmeyer JD, Stukel TA, Siewers AE et al. (2003) Surgeon volume and operative mortality in the Unites States. N Engl J Med 349: 2117–27

    Article  CAS  PubMed  Google Scholar 

  10. Hulscher JB, van Sandick JW, de Boer AG et al. (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347: 1662–9

    Article  PubMed  Google Scholar 

  11. Miller JL, Mc Intyre MD, Hatcher CR (1985) Combined treatment approach in surgical management of carcinoma of the esophagus: a preliminary report. Ann Thorac Surg 40: 289

    CAS  PubMed  Google Scholar 

  12. Lokich JJ, Shea M, Chaffey J (1987) Sequential infusion 5-fluoro-uracil followed by concomitant radiation for tumors of the esophagus and the gastroesophageal junction. Cancer 60: 275–9

    CAS  PubMed  Google Scholar 

  13. Ajani JA, Ilson DH, Daugherty K et al. (1994) Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Invest 86: 1086–91

    CAS  Google Scholar 

  14. Muro K, Hamaguchi T, Ohtsu A et al. (2004) A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15: 955–9

    Article  CAS  PubMed  Google Scholar 

  15. Conroy T, Etienne PL, Adenis A et al. (1996) Phase II trial of vinorelbine in metastatic squamous cell carcinoma. J Clin Oncol 14: 164–70

    CAS  PubMed  Google Scholar 

  16. Kok TC (1997) Chemotherapy in esophageal cancer. Cancer Treatment Reviews 23: 65–85

    Article  CAS  PubMed  Google Scholar 

  17. Taieb J, Artru P, Baujat B et al. (2002) Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer. Eur J Cancer 38: 661–6

    CAS  PubMed  Google Scholar 

  18. Mitry E, Taieb J, Artru P et al. (2004) Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5-FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Ann Oncol 15: 765–9

    CAS  PubMed  Google Scholar 

  19. Conroy T, Etienne PL, Adenis A et al. (2002) Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 13: 721–9

    Article  CAS  PubMed  Google Scholar 

  20. Kroep JR, Pinedo HM, Giaccone G et al. (2004) Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Ann Oncol 15: 230–5

    Article  CAS  PubMed  Google Scholar 

  21. Ilson DH, Saltz L, Enzinger P et al. (1999) Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 1117: 3270–5

    Google Scholar 

  22. Ajani JA, Baker J, Pisters PW et al. (2002) CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 94: 641–6

    Article  CAS  PubMed  Google Scholar 

  23. Ilson DH, Forastiere A, Arquette M et al. (2000) A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer 6: 316–23

    CAS  Google Scholar 

  24. Ilson DH, Ajani J, Bhalla K et al. (1998) Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16: 1826–34

    CAS  PubMed  Google Scholar 

  25. Lokich JJ, Sonneborn H, Anderson NR et al. (1999) Combined paclitaxel, cisplatin, and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas. Cancer 85: 2347–51

    CAS  PubMed  Google Scholar 

  26. Bleiberg H, Conroy T, Paillot B et al. (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33: 1216–20

    CAS  PubMed  Google Scholar 

  27. Tebbutt NC, Norman A, Cunningham D et al. (2002) A multicentre, randomised phase III trial comparing proctracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer. Ann Oncol 13: 1568–75

    Article  CAS  PubMed  Google Scholar 

  28. Webb A, Cunningham D, Scarffe JH et al. (1997) Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15: 261–7

    CAS  PubMed  Google Scholar 

  29. Ross P, Nicolson M, Cunningham D et al. (2002) Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20: 1996–2004–10–29

    Article  CAS  PubMed  Google Scholar 

  30. Assersohn L, Brown G, Cunningham D et al. (2004) Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 15: 64–9

    Article  CAS  PubMed  Google Scholar 

  31. Lordick F, von Schilling C, Bernhard H et al. (2003) Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer. Br J Cancer 89: 630–3

    Article  CAS  PubMed  Google Scholar 

  32. Ilson DH, Kelsen DP (1994) Combined modality therapy in the treatment of esophageal cancer. Sem Oncol 21: 493–507

    CAS  Google Scholar 

  33. Roth JA, Pass HI, Flanagan MM et al. (1988) Randomised clinical trial preoperative and postoperative chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96: 242–8

    CAS  PubMed  Google Scholar 

  34. Schlag PM (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 127: 1446–50

    CAS  PubMed  Google Scholar 

  35. Maipang T, Vasinanukorn P, Petpichetchian C et al. (1994) Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 56: 191–7

    CAS  PubMed  Google Scholar 

  36. Kok TC, Van Lanschot J, Siersema PD et al. (1997) Neoadjuvant chemotherapy in operable oesophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 16: 277a.

    Google Scholar 

  37. Law S, Fok M, Chow S et al. (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114: 210–7

    CAS  PubMed  Google Scholar 

  38. Kelsen DP, Ginsberg R, Pajak TF et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Eng J Med 339: 1979–84

    CAS  Google Scholar 

  39. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727–33

    Google Scholar 

  40. Ando N, Iizuka T, Kakegawa T et al. (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan clinical oncology group study. J Thorac Cardiovasc Surg 114: 205–9

    CAS  PubMed  Google Scholar 

  41. Ando N, Iizuka T, Ide H et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG 9204. J Clin Oncol 21: 4592–6

    Article  PubMed  Google Scholar 

  42. Pouliquen X, Levard H, Hay JM et al. (1996) 5-fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. Ann Surg 223: 127–33

    Article  CAS  PubMed  Google Scholar 

  43. Launois B, Delarue D, Campion JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153: 690–2

    CAS  PubMed  Google Scholar 

  44. Gignoux M, Roussel A, Paillot B et al. (1987) The value of preoperative radiotherapy in oesophageal cancer: results of a study of the EORTC. World J Surg 11: 426–32

    Article  CAS  PubMed  Google Scholar 

  45. Wang M, Gu XZ, Yin WB et al. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16: 325–7

    CAS  PubMed  Google Scholar 

  46. Arnott SJ, Duncan W, Kerr GR et al. (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24: 108–13

    Article  CAS  PubMed  Google Scholar 

  47. Nygaard K, Hagen S, Hansen HS et al. (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer. World J Surg 16: 1104–9

    Article  CAS  PubMed  Google Scholar 

  48. Iizuka T, Ide H, Kakegawa T et al. (1988) Preoperative radioactive therapy for esophageal carcinoma: Randomized evaluation in eight institutions. Chest 93: 1054–8

    CAS  PubMed  Google Scholar 

  49. Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 173: 123–30

    CAS  PubMed  Google Scholar 

  50. Fok M, Sham JST, Choy D et al. (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized, controlled study. Surgery 113: 138–47

    CAS  PubMed  Google Scholar 

  51. Zieren HU, Müller JM, Jacobi CA et al. (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 19: 444–9

    Article  CAS  PubMed  Google Scholar 

  52. Caspers RJ, Welvaart K, Verkes RJ et al. (1988) The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother Oncol 12: 15–23

    Article  CAS  PubMed  Google Scholar 

  53. Jager J, Langendijk H, Pannebakker M et al. (1995) A single session of intraluminal brachytherapy in palliation of esophageal cancer. Radiother Oncol 37: 237–40

    Article  CAS  PubMed  Google Scholar 

  54. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in oesophageal cancer. Hepatogastroenteroly 41: 391–3

    CAS  Google Scholar 

  55. Le Prise E, Etienne PL, Meunier B et al. (1994) A randomised study of chemoradiotherapy, radiation therapy and surgery versus surgery for localised squamous cell carcinoma of the esophagus. Cancer 73: 1779–84

    PubMed  Google Scholar 

  56. Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462–7

    CAS  PubMed  Google Scholar 

  57. Bosset JF, Gignoux M, Triboulet JP et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell carcinoma of the oesophagus. N Engl J Med 337: 161–7

    Article  CAS  PubMed  Google Scholar 

  58. Urba SG, Orringer MB, Turrisi A et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305–13

    CAS  PubMed  Google Scholar 

  59. Burmeister BH, Smithers BM, Fitzgerald L et al. (2002) A randomized phase III trial of preoperative chemoradiation followed by surgery alone (s) for localized resectable cancer of the esophagus. Proc Am Soc Clin Oncol 21: A518

    Google Scholar 

  60. Lee JL, Park SI, Kim SB et al. (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for respectable esophageal squamous cell carcinoma. Ann Oncol 15: 947–54

    Article  CAS  PubMed  Google Scholar 

  61. Calais G (1998) Chimioradiothérapie concomitante du cancer de l’æsophage. Cancer Radiother 2: 689–95

    CAS  PubMed  Google Scholar 

  62. Kolaric K, Maricic Z, Roth A, Dujmovic I (1980) Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. Cancer 45: 2265–73

    CAS  PubMed  Google Scholar 

  63. Araujo CM, Souhami L, Gil RA et al. (1991) A randomized trail comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67: 2258–61

    CAS  PubMed  Google Scholar 

  64. Herskovic A, Martz K, Al-Sarraf M et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Eng J Med 326: 1593–8

    CAS  Google Scholar 

  65. Al-Sarraf M, Martz K, Herskovic A et al. (1997) Progress report of combined chemo-radiotherapy versus radiotherapy alone in patients with esophageal cancer. J Clin Oncol 15: 277–84

    CAS  PubMed  Google Scholar 

  66. Roussel A et al. (1994) results of the EORTC-GTCCG phase III trial inoperable esophageal cancer. Proc Am Soc Clin Oncol A583

    Google Scholar 

  67. Smith TJ, Ryan LM, Douglass HO Jr et al. (1998) Combined chemoradiotherapy versus radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42: 269–76

    Article  CAS  PubMed  Google Scholar 

  68. Slabber CF, Nel JS, Schoeman L et al. (1998) A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 21: 462–5

    Article  CAS  PubMed  Google Scholar 

  69. Gaspar LE, Qian C, Kocha WI et al. (1997) A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Int J Radiat Oncol Biol Phys 37: 593–9

    CAS  PubMed  Google Scholar 

  70. Calais G, Dorval E, Louisot P et al. (1997) Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for stages IIB and III esophageal carcinoma: results of a pilot study. Int J Radiat Oncol Biol Phys 38: 769–75

    Article  CAS  PubMed  Google Scholar 

  71. Minsky BD, Pajak TF, Ginsberg RJ et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 20: 1167–74

    Article  CAS  PubMed  Google Scholar 

  72. Wang Y, Shi XH, He SQ et al. (2002) Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 54: 131–6

    PubMed  Google Scholar 

  73. Minsky BD, Neuberg D, Kelsen DP et al. (1999) Final report of intergroup trial 0122 (ECOG PE-289, RTOG 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous-cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43: 517–23

    Article  CAS  PubMed  Google Scholar 

  74. Khushalani NI, Leichman CG, Proulx G et al. (2002) Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20: 2844–50

    Article  CAS  PubMed  Google Scholar 

  75. Bedenne L, Michel P, Bouche O et al. (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) Proc Am Soc Clin Oncol 21: A518

    Google Scholar 

  76. Stahl M, Stuschke M, Lehman N et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23: 2310–17

    Article  PubMed  Google Scholar 

Download references

Authors
  1. P. Artru
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Artru, P. (2006). Cancer de l’Œsophage. In: Les cancers digestifs. Oncologie Pratique. Springer, Paris. https://doi.org/10.1007/2-287-30874-1_5

Download citation

  • DOI: https://doi.org/10.1007/2-287-30874-1_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-22087-6

  • Online ISBN: 978-2-287-30874-1

Publish with us

Policies and ethics

Search

Navigation